GINGER MULLINS: Open Payments
NPI 1659469690 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,110 in 115 payments from 25 companies in 2025. Trend: 2023 $1,988 · 2024 $2,181 · 2025 $2,110
Food & beverage: $2,110
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $364 |
| Lilly USA, LLC | 16 | $269 |
| AstraZeneca Pharmaceuticals LP | 10 | $185 |
| ABBVIE INC. | 11 | $180 |
| PFIZER INC. | 7 | $138 |
| Otsuka America Pharmaceutical, Inc. | 6 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $108 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Abbott Laboratories | 3 | $63 |
Products named: MOUNJARO, Ozempic, JARDIANCE, REXULTI, AIRSUPRA, Rybelsus, NURTEC ODT, UBRELVY.
Industry payments across TN — which companies pay providers there.
